PO. Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats. Am J Physiol Regul Integr Comp Physiol 297: R26 -R33, 2009. First published April 1, 2009 doi:10.1152/ajpregu.90617.2008.-Patients with congestive heart failure (CHF) experience increased skeletal muscle fatigue. The mechanism underlying this phenomenon is unknown, but a deranged extracellular matrix (ECM) might be a contributing factor. Hence, we examined ECM components and regulators in a rat postinfarction model of CHF. At various time points during a 3.5 mo-period after induction of CHF in rats by left coronary artery ligation, blood, interstitial fluid (IF), and muscles were sampled. Isoflurane anesthesia was employed during all surgical procedures. IF was extracted by wicks inserted intermuscularly in a hind limb. We measured cytokines in plasma and IF, whereas matrix metalloproteinase (MMP) activity and collagen content, as well as the level of glycosaminoglycans and hyaluronan were determined in hind limb muscle. In vivo fatigue protocols of the soleus muscle were performed at 42 and 112 days after induction of heart failure. We found that the MMP activity and collagen content in the skeletal muscles increased significantly at 42 days after induction of CHF, and these changes were time related to increased skeletal muscle fatigability. These parameters returned to sham levels at 112 days. VEGF in IF was significantly lower in CHF compared with sham-operated rats at 3 and 10 days, but no difference was observed at 112 days. We conclude that temporary alterations in the ECM, possibly triggered by VEGF, are related to a transient development of skeletal muscle fatigue in CHF.
PATIENTS WITH CONGESTIVE HEART FAILURE (CHF) frequently experience increased skeletal muscle fatigue. Also, and in contrast to the healthy individual, cardiac output relates poorly to the exercise capacity of CHF patients (10, 45) . Both animal studies and clinical studies have identified structural, biochemical, and functional abnormalities within skeletal muscle in CHF. For example, a fiber-type switch toward a less fatigueresistant phenotype (36, 44) , impaired calcium handling (18, 26) , altered myocyte calcium sensitivity (18) , and reduced oxidative capacity (5, 20) have been reported. Consistently, increased fatigability of the rat skeletal muscle in CHF has been demonstrated both in vivo (16) and on a single-fiber level (18) . Importantly, in these CHF rats, blood flow to the exercising soleus muscle was unaltered compared with shamoperated rats (30) .
Research on muscular fatigue in CHF has focused on the skeletal muscle fiber itself, while possible alterations of the adjacent extracellular matrix (ECM) and its components have apparently not been explored in detail. Interestingly, biomarkers of ECM remodeling and collagen turnover were recently demonstrated to be positively correlated to both mortality and morbidity in CHF patients (27) . In a previous study (17) , we noted that the flexor digitorum brevis muscle (a fast-twitch muscle) in postinfarction CHF rats was more fragile during dissection compared with sham-operated rats, despite the absence of atrophy and edema (16) . This led to the assumption that ECM might be altered in CHF, and we therefore investigated the role of matrix metalloproteinases (MMPs) in the skeletal muscle of CHF rats. We found increased MMP activity in both fast-and slow-twitch skeletal muscles of CHF rats compared with sham 6 wk after induction of myocardial infarction (31) . These findings were later supported by others (3) .
Force transmission from the myocytes to the bone is dependent on the structural integrity between individual muscle fibers and the ECM (2) . The connective tissue, dominated by collagen, is of particular importance for this force transmission as it interacts closely with the contractile elements of the muscle (14) . Furthermore, proteoglycans are of importance in linking together the fibrous structures of the ECM (32, 42) . Alterations in ECM components can, therefore, contribute to decreased resistance to fatigue.
CHF is characterized by elevated plasma levels of proinflammatory cytokines (9, 23) that increase with disease severity and have prognostic value (4, 24, 38) . This supports the notion that elevated levels of cytokines may reflect important pathogenic mechanisms in this disease. What causes the skeletal muscle alterations in CHF is poorly understood, but humoral factors, like proinflammatory cytokines, might be the link between the failing heart and the altered skeletal muscle. Several cytokines and growth factors have the potential to alter skeletal muscle ECM. For example, IL-1␤ can induce a marked increase in MMP activity (1) and transforming growth factor (TGF)-␤ has been shown to stimulate collagen formation and reduce its degradation (7, 25) , as well as increasing the synthesis of proteoglycans (28) . IL-6, known to be produced by skeletal muscle fibers, is also released by fibroblasts (41) and can stimulate their production of collagen, sulfated glycosaminoglycans, and hyaluronan (6) .
On this basis, we now wanted to examine MMPs, relevant cytokines, both in plasma and locally within skeletal muscle, as well as possible alterations of structural components of the ECM during progression of ischemic heart failure in rats.
We hypothesized that induction of ischemic heart failure in rats would lead to an early cytokine response that would alter the structural integrity of skeletal muscle-ECM and thereby contribute to decreased resistance to fatigue.
MATERIALS AND METHODS
Experimental model. The investigation was conducted in accordance with APS's Guiding Principles in the Care and Use of Animals and was approved by the Norwegian Animal Research Authority. Two animals were housed per cage and given access to food and water ad libitum in a temperature-regulated room on a 12:12-h light-dark cycle.
Under anesthesia (68% N 2O/29% O2/1.5 to 2% isoflurane; Abbot Scandinavia, Solna, Sweden), male Wistar rats (Taconic, Skensved, Denmark; ϳ320 g body wt) were subjected to ligation of the left coronary artery (CHF) or a sham operation, as described previously (34) . At 3, 10, 42, and 112 days after this primary operation, rats were again anesthetized and echocardiography was performed using a Vivid 7 echocardiograph (GE Vingmed Ultrasound, Horten, Norway) with a 12-MHz linear array transducer (M12L) (34) . Left ventricle end-diastolic pressure (LVEDP) was determined by a 0.67-mm microtip pressure catheter (SPR-407; Millar Instruments, Houston, TX) inserted through the right carotid artery and into the left ventricle. Only rats with LVEDP Ն 15 mmHg were included in the CHF group in subsequent experiments (34) . After these measurements, the soleus (SOL), tibialis anterior and extensor digitorum longus (EDL) muscles of one limb were carefully removed. Because intermuscular wicks were inserted in one hindlimb of each animal, only one set of hindlimb muscles were available for the remaining analysis. We considered using different muscles for different analysis to be appropriate to restrict the use of animals to an acceptable level. Blood was sampled from the abdominal aorta into a Vacutainer citrate tube and added 100 l of 1 M HEPES (pH 7.2-7.4) and 100 l of mM CaCl 2 before centrifugation at 1,100 g for 10 min at 4°C. The animal was killed after the heart and lungs were removed during deep anesthesia.
Collection of wick interstitial fluid from hind limb muscle. Muscle interstitial fluid (IF) was sampled by intermuscular wick implantation as detailed (43) . Three-stranded nylon wicks (diameter, 1 mm; length, 5-7 cm) prewashed in acetone, ethanol, and distilled water were used. Dry wicks were inserted intermuscularly post mortem in hindlimb muscle between the adductor magnus and gracilis muscles, and the semimembranosus and semitendinosus muscles rather than the SOL and EDL muscles, as the latter two were used for other measurements. The wicks were then left to absorb IF for 15-20 min before removal and transferral to centrifuge tubes with funnels containing 1.5 ml mineral oil with 5 l protease inhibitor cocktail (Roche, Mannheim, Germany) to avoid degradation of cytokines in the IF. To prevent evaporation, all wick handling took place in an incubator kept at 100% relative humidity. Wick fluid was isolated under mineral oil by centrifugation at ϳ 21,000 g for 10 min, aspirated by a pipette and stored at Ϫ80°C until further analyses.
Cytokine analysis. A panel of cytokines were quantified in IF and plasma. A multiplex fluorescent bead immunoassay kit (Linco Research, St. Charles, MO) was used for the simultaneous quantification of the following cytokines: IL-1␣, IL-1␤, IL-2, IL-6, IL-10, growth regulated oncogene-KC (GRO-KC), IFN-␥, TNF-␣, VEGF, chemokine (C-C motif) ligand 2 (CCL2) [monocyte chemotactic protein 1 (MCP-1)], and CCL3 [macrophage inflammatory protein-1␣ (MIP-1␣)]. The samples were prepared for analysis by dilution with serum matrix diluent, and the analysis was performed as specified by the manufacturer. Total surface fluorescence was measured with a flowbased dual-laser system (Luminex 100 , Luminex, Austin, TX). The lower detection level was 4.8 pg/ml.
Transforming growth factor-␤1. TGF-␤1 in plasma and IF were measured with an ELISA kit (Bender MedSystems, Vienna, Austria) according to specifications given by the manufacturer. The plasma and wick fluids were first diluted 1:20 with assay buffer. For each well, the optical density at 450 nm was recorded with Spectramax plus 384 microplate reader (Molecular Devices, Sunnyvale, CA). The lower detection level was 0.47 ng/ml.
Collagen content. Assessment of total collagen content in the tibialis anterior muscle was based on the hydroxyproline content (46) . Muscles were collected as described above. Approximately 20 -50 mg of freeze-dried and homogenized muscle was placed in glass vials; 1 ml 6 M HCl was added and left to hydrolyze overnight at 120°C. After cooling, 3 ml of distilled water was added. The solution was pipetted into a total volume of 4.5 ml, so that the tissue concentration in all samples reached 0.25 mg/ml. Five-hundred microliters of diluted hydrolyzed sample was pipetted into a test tube, and 250 l of 0.05 M Chloramine-T reagent was added to the sample before it was mixed and incubated at room temperature for 20 min. Two-hundred-and-fifty microliters of 3.15 M perchloric acid was added and left to incubate at room temperature for 5 min before adding 250 l of 20% (wt/vol) of p-dimethylaminobenzaldehyde dissolved in ethylenglycolmonoethylether. After mixing, the tubes were placed in a waterbath at 60°C and then in ice water for 5 min before the absorbance was read at 557 nm with the Spectramax plus 384 spectrophotometer. The concentration of hydroxyproline was quantified by comparison with a standard curve in the range of 0.5-6 g/ml, based on a stock solution of 25 mg L-4-hydroxyproline (Fluka Chemie GmbH, Buchs, Switzerland) dissolved in 250 ml 1 mM HCl. Collagen content was determined using an estimate of 6.94 g collagen/g hydroxyproline (13) .
Assessment of collagen type III was performed on muscle tissue samples from EDL and SOL. Separation of proteins were performed on 10% SDS gels. After blotting, the polyvinylidene difluoride membranes were incubated with primary antibody against collagen III (1:5,000, #600 -401-105; Rockland, Gilbertsville, PA) overnight at 4°C. Secondary antibody was NA934V (Amersham Biosciences/GE Healthcare Bio-Sciences, Piscataway, NJ). The signal from the immunoactive spots was visualized with Enhanced Chemiluminescence Plus detection system (RPN 2132; Amersham, Oslo, Norway). Detection of bands was done with LAS 4000 (Fujifilm, Sverige, Sweden) and quantified with Imagequant (GE Healthcare).
MMP activity. MMP activity was measured with a gelatinase assay, as detailed previously (31) . Briefly, SOL and EDL muscles were carefully isolated and stripped for tendons and connective tissue before immediate transfer to ice-cold PBS. In the gelatinase assay, calf skin 3 H-collagen (Sigma-Aldrich, Steinheim, Germany) was used as a substrate. The acid-soluble radioactive protease products were measured in a liquid scintillation counter (Wallac Win Spectral 1414, PerkinElmer Instruments, Oslo, Norway). Because of the slight variations in the incorporation of radioactivity when preparing the different gels, the results had to be standardized (31) . To this end, the gelatinase activity obtained from muscle samples of CHF rats were normalized to those obtained from sham-operated rats in the same analytical run (i.e., run on the same gel) to yield a relative value. Sham value was set to 1.0.
Hyaluronan analysis. Hyaluronan in EDL muscle was analyzed using an ELISA kit (Corgenix UK, Peterborough, UK). Approximately 25 mg of freeze-dried and homogenized muscle was placed in glass vials and added 1 ml of 0.5 mg/ml Pronase E (Sigma-Aldrich, St. Louis, MO) dissolved in Tris ⅐ HCl/CaCl2 buffer (0.05/0.01 M, pH 7.2). The vials were incubated for ϳ24 h at 56°C, and then boiled in 13 min in a water bath, followed by cooling and centrifugation in 10 min at 464 g. The sample solution was then diluted 1:500 with assay buffer, before further analysis was performed according to specifica-tions given by the manufacturer. The plates were precoated with hyaluronan antibodies, and standards and experimental samples were added. For each well, the optical density at 450 nm was read using the Spectramax plus 384 microplate reader. The lower detection level was 50 ng/ml.
Isolation of glycosaminoglycans. Isolation of glycosaminoglycans (GAGs) was based on the method of Ledin et al. (15) . Frozen muscle samples (EDL and SOL) were cut into small pieces (14 -43 mg dry weight) and treated with Pronase E (Sigma Aldrich; 0.8 mg/ml) in 0.5 ml of buffer (50 mM Tris ⅐ HCl, pH 8.0, 1 mM CaCl 2, and 1% Triton X-100) at 55°C overnight. Subsequently, 0.4 mg of Pronase E was added, and the samples were incubated for 2 h. After inactivation by boiling and adjustment of the samples to 2 mM MgCl 2, 12 mU of endonuclease (Sigma-Aldrich) were added and incubated for 2 h at 37°C and, after heat inactivation of the enzyme, adjusted to a final concentration of 0.1 M NaCl. Subsequently, the samples were centrifuged at 14,000 g for 10 min. The GAG chains were desalted and purified by ion-exchange chromatography on 0.3 ml DEAE-Sephacel columns. The ion-exchange columns were primed by washing with 2 M NH 4HCO3 and a loading buffer of pH 8.0 (50 mM Tris ⅐ HCl, pH 8.0, 0.1 M NaCl, and 0.1% Triton X-100). The supernatants from the digestions were applied, and the columns were washed successively with a loading buffer of pH 8.0, a washing buffer of pH 4.0 (50 mM sodium acetate, 0.1 M NaCl, and 0.1% Triton X-100), and finally with 0.2 M NH 4HCO3. The GAG chains were eluted in 3 ϫ 0.3 ml portions of 2 M NH4HCO3. The eluates were collected in microcentrifuge tubes and repeatedly freeze dried until the pH values were close to 7.
For chondroitin sulfate (CS) degradation, the GAG pools were digested with 50 mU of chondroitinase ABC (cABC) (Seikagaku, Tokyo, Japan) in 50 l of 40 mM Tris-acetate buffer, pH 8.0. CS digestion was performed for 3 h at 37°C, followed by heat inactivation. cABC will also degrade hyaluronan to disaccharides, so the disaccharide analysis of CS will, therefore, contain both hyaluronan disaccharides and CS disaccharides. Samples were dried and dissolved in 100 l H 2O. From the CS digests, 10 l was removed for analysis of CS disaccharides by reverse-phase ion pair high-performance liquid chromatography (RPIP-HPLC; see below). For heparan sulfate (HS) disaccharide preparation, 90 l of the CS digest was filtrated with a 3 kDa cut-off Microcon filter (Millipore, Billerica, MA). The concentrate containing intact HS-GAGs was freeze dried and dissolved in 20 l of H 2O. Two aliquots were dried and prepared for heparitinase digestion. One aliquot was treated with 0.4 mU of heparitinases I, II, and III (Grampian Enzymes, Orkney, Scotland, UK) in 15 l of heparitinase buffer (5 mM HEPES, pH 7.0, 50 mM NaCl, 1 mM CaCl 2, 0.7 mg/ml BSA) and incubated for 16 h at 37°C. The other aliquot was incubated without enzymes. The reaction was stopped by heat inactivation. All of the samples were dried and dissolved in 45 l H 2O before analysis with RPIP-HPLC.
Analysis of disaccharides. Quantitative analysis of disaccharides derived from GAGs was performed by RPIP-HPLC (35) on a Luna 5 C18 reversed-phase column (4.6 ϫ 150 mm; Phenomenex, Torrance, CA) in 8.5% acetonitrile and 1.2 mM hydrogen sulfate (Fluka, St. Louis, MO) by applying a stepwise gradient from 1 to 53% of 0.2 M NaCl (39). The flow rate was 1.1 ml/min, and the fluorescent labeling reaction was performed by the addition of 2-cyanoacetamide (0.25%; Sigma) in NaOH (0.5%; 0.35 ml/min). Signals were quantified against standards (Sigma and Grampian Enzymes). The chromatography software used was Chromeleon (Dionex, Sunnyvale, CA).
Fatigue protocol. At 42 and 112 days, we performed an in vivo isometric fatigue protocol on SOL of CHF and sham-operated rats, as described in detail elsewhere (16) . In short, the rats were anesthesized, and blood pressure and LVEDP were monitored by a catheter inserted into the left ventricle as described above. SOL was denervated and then electrically stimulated at 5 Hz for 6 s at 10-s intervals for 30 min with 1-ms pulses. Blood supply to the working muscle was intact, and muscle core temperature was maintained at 39°C. The foot and the tibia of the rat were fixed by two clamps and the distal tendon of the muscle was attached to a force transducer and positioned in parallel to the tibia. The muscle was stretched, and stimulation voltage was adjusted to give maximal force of tetanic contractions. Maximum force during the stimulation train, as well as contraction rate of the first contraction and relaxation rate of the last contraction of each train, were calculated.
Statistics. Values are expressed as means Ϯ SE. Statistically significant differences were assumed for P Ͻ 0.05. To evaluate time-dependent differences between CHF and sham, a two-way ANOVA with CHF and time as variables was used, whereas the Bonferroni correction was used for post hoc analysis. For the GAG analysis, a Student's t-test was used since the time points were pooled and only the 2 study groups were compared. The MMP activity in muscle samples of CHF rats were normalized to those obtained from sham-operated rats in the same analytical run to yield a relative value. Accordingly, a one-sample t-test was used at each time point followed by a Bonferroni correction to see whether the MMP activity in CHF muscles was significantly different from 1.
RESULTS
Induction of postinfarction heart failure. As shown in Table 1 , we found effects of CHF (P Ͻ 0.0001) and time (P Ͻ 0.05) on lung weight (LW), LVEDP and left atrial diameter (LAD), and there was interaction (P Ͻ 0.05) between the two variables for both LVEDP and LAD. Post hoc analysis showed that LW of CHF animals were elevated (P Ͻ 0.0001) at all time points (Table  1) , indicating pulmonary congestion. In line with this, LVEDP and LAD also increased (P Ͻ 0.0001) among CHF rats compared with sham-operated rats at all time points. In addition, cardiac output decreased in the CHF animals at these time points (P Ͻ 0.0001). There was an overall effect of time, but not of CHF on body weight (Table 1) . For additional echocardiographic parameters and animal characteristics, we refer to online supplemental material. Values are expressed as means Ϯ SE; number of animals appears in parenthesis. Body weight, lung weight, left ventricle end-diastolic diameter (LVEDP), left atrial diameter (LAD) and cardiac output (CO) in congestive heart failure (CHF) rats compared to sham at 3, 10, 42, and 112 days after primary surgery. *P Ͻ 0.05 compared with respective sham as measured by two-way ANOVA followed by the Bonferroni correction.
A temporary increase of MMP activity and collagen content.
Gelatinase activity, as a measure of MMP-related activity, within isolated SOL (a slow-twitch muscle) and EDL (a fasttwitch muscle) was determined at 3, 10, 42 and 112 days after induction of CHF. There was no difference (P Ͼ 0.05) in MMP activity between CHF and sham at 3 days (Fig. 1) . However, the CHF group exhibited a significantly higher MMP activity in the SOL muscle after 10 days and in the SOL and EDL muscles after 42 days, compared with sham-operated rats. The MMP activity had returned to the sham level by 112 days.
At the same time points, collagen content of the tibialis anterior muscle (predominantly a fast-twitch muscle) from the same animals was assessed. There were significant effects of both time and CHF, but no significant interaction between the two variables. Post hoc analysis revealed that collagen content of this muscle, as expressed in percent dry weight, was moderately elevated in the CHF group at 42 days (P Ͻ 0.05), coinciding in time with the upregulation of MMP activity (Fig. 2) . At the other specific time points, there were no significant differences between the two groups. There was no difference in content of collagen type III between CHF and sham-operated rats for either EDL or SOL muscle (Fig. 3) .
Muscle structures of sulfated GAGs and hyaluronan. To investigate whether the composition of muscle GAGs was altered in CHF animals, GAGs were isolated from SOL and EDL muscles at 3, 10, 42, and 112 days after the primary operation. The results showed that HS, as well as CS ϩ hyaluronan, from both SOL and EDL muscles consisted of similar disaccharides and in similar ratios. Furthermore, the distribution (in percent of total) of the different disaccharides in HS and CS ϩ hyaluronan was not affected in CHF animals in the two types of muscle analyzed (data presented in supplemental material in the online version of this article). From the HPLC chromatogram, it was also possible to calculate the ratio z z Fig. 1 . Matrix metalloproteinase (MMP) activity of the soleus (SOL) and extensor digitorum longus (EDL) muscles in congestive heart failure (CHF) and sham-operated animals. *Significantly increased MMP activity in CHF compared with sham-operated rats at the specified time points as measured by one sample t-test followed by a Bonferroni correction (P Ͻ 0.05). Values are expressed as means Ϯ SE, and the number of rats per time point is noted in parentheses. of CS ϩ hyaluronan/HS in each preparation. The ratio was 3:1 in all muscles analyzed, and no apparent difference was observed between sham and CHF muscles. The hyaluronan content of EDL muscles, as analyzed by ELISA, was also similar in the two groups at all time points (Data are presented in supplemental material in the online version of this article).
Reduced interstitial levels of VEGF in CHF. To detect changes in cytokine concentrations and their gradients during progression of CHF, cytokines were measured in both plasma and IF at all four time points. For VEGF, there was an effect of CHF (P Ͻ 0.05) and interaction with time (P Ͻ 0.05). Post hoc analysis revealed a lower concentration of VEGF in the IF of CHF animals compared with sham at the two earliest time points (P Ͻ 0.0001 and P Ͻ 0.05 at 3 and 10 days, respectively) (Fig. 4A) . By measuring both plasma and IF concentrations, we were able to determine the cytokine concentration gradients between these two compartments. This revealed a large concentration gradient of VEGF from IF toward plasma in both groups. For all the other cytokines analyzed (IL-1␣, IL-1␤, IL-2, IL-6, IL-10, GRO-KC, IFN-␥, TNF-␣, CCL2, CCL3, and TGF-␤1), there were no significant differences, either in plasma or in the IF, between the two groups (for details, see supplemental material in the online version of this article).
Temporarily increased fatigability in CHF.
Maximal force development and contraction and relaxation time were obtained for CHF and sham animals at 42 and 112 days. At 42 days, we found effects of CHF on these three parameters (P Ͻ 0.0001), and for maximal force, there was also an effect of time (P Ͻ 0.05). Despite the overall higher maximal force development in the CHF group at 42 days, post hoc tests did not reveal any significant differences at the specific time points during the fatigue protocol (Fig. 5A) . Initial maximal force at 42 days was 99.4 Ϯ 1.4 g and 90.1 Ϯ 6.6 g for the CHF and sham group, respectively. Hence, the CHF rats, although having an overall higher force production than sham-operated rats, displayed a reduction in force toward the end of the fatigue protocol, obtaining values similar to that of sham-operated rats (Fig. 5A) . There was an overall increased relaxation time in the CHF group compared with sham (P Ͻ 0.05) and with significant interaction with time. Post hoc analysis detected significantly slower relaxation rates at the two latest time points in the fatigue protocol (Fig. 5C ). The CHF rats also displayed overall slower contraction rates compared with sham. Post hoc tests revealed significant slower contraction rates at the three latest time points (Fig. 5B) . At 112 days, there were no differences in maximum force, contraction rates, or relaxation rates compared with sham (Fig. 5, D-F) .
DISCUSSION
The underlying hypothesis of the present study was that the increased muscular fatigue associated with CHF, confirmed both by experimental rat studies (16, 18, 26) , as well as clinical studies (19, 21) , might be caused by changes in ECM. In line with this, the progression of CHF and skeletal muscle fatigability was accompanied by an increase in collagen content and MMP activity at 42 days. At 112 days, however, both the collagen content and MMP activity had returned to sham levels, and there were no differences with respect to fatigability at this time point. Furthermore, the CHF animals exhibited a reduced level of VEGF in muscle IF at early time points. Collectively, these findings suggest that although a marked and stable postinfarction heart failure condition develops in the CHF rats, skeletal muscle fatigue, and alterations in skeletal muscle ECM are temporary.
Induction of heart failure by ligation of the left coronary artery in the rat is an established model (34) that mimics the development of human postinfarction heart failure. However, the possible impact of, for example, atherosclerosis cannot be accounted for in this model. On the basis of previous studies (16, 31) , it is our opinion that 8 -10 samples for the different analysis would be sufficient to detect physiologically relevant differences between the groups. We were not, however, able to do a formal power analysis. Technical and logistic circumstances resulted in some variation in sample size for the different analysis, as well as for the different time points. Neither muscle weights nor changes in specific tension of the muscles were measured and could be regarded as a limitation of the study. However, we have previously demonstrated that there is no difference in muscle weight or muscle water content, either in fast-or in slow-twitch skeletal muscle, between CHF and sham animals up until 17 wk in this model (18) . This indicates that there is no muscle atrophy or muscle edema in the CHF animals. The present method for IF isolation has been thoroughly validated (43) . By implanting wicks post mortem after circulatory arrest, we avoided net transcapillary transport of fluid and protein between tissue and the vascular compartment, thereby avoiding any vascular reactions to the wick implantation. Furthermore, by placing wicks between adjacent muscles, we minimized the possibility of cell damage and contamination of interstitial fluid with cell proteins. In our opinion, fluid from wicks implanted intermuscularly post mortem reflects the composition of native IF (43) .
Previously, we have reported that CHF is accompanied by increased MMP activity in both the EDL and the SOL muscles at 42 days (31) . In that study, we found no differences in mRNA expression, either at protein level of MMP-9 or MMP-2, or in the activity of tissue inhibitors of MMPs (TIMP-1 and TIMP-2) (31). Carvalho et al. (3) have also reported increased MMP activity in skeletal muscle of rats with CHF induced by monocrotaline, a toxic compound causing right-sided heart failure secondary to pulmonary hypertension, but they did not investigate to what extent the toxin per se could affect skeletal muscle properties. Moreover, they performed their analysis at an early time point (22 days after administration of the drug). In addition to the increased MMP activity at 42 days, we found a concomitant moderate increase in collagen content of the tibialis anterior muscle in the CHF animals. These alterations, although also temporary, may reflect a transient disruption of the structural integrity of ECM in the skeletal muscle of CHF animals, initially caused by ligation of the left coronary artery. Among the about 30 subtypes of hitherto described collagens, most with different functions, we chose to examine collagen type III since the plasma level of N terminal type III collagen reportedly is a strong predictor of functional capacity and clinical outcome in CHF patients (27) , indicating that turnover of collagen III in ECM might be of pathophysiological importance in CHF. In the present study we found no alterations in collagen III content of fast-or slowtwitch skeletal muscle. It is, therefore, likely that the measured increase in total amount of collagen is due to alterations of other collagen types. A candidate initiator of the increased collagen content could be TGF-␤, a well-known profibrotic stimulus (29, 33) , but it was not increased in IF of CHF rats at any time point in the present study.
All previous studies on muscle fatigue in CHF animals have been performed about 6 wk after primary surgery, and they all suggest reduced contractile function and increased fatigability of skeletal muscle in CHF compared with sham (16 -18, 26, 37) . We are apparently the first to assess contractile function and fatigability of skeletal muscle in CHF animals beyond 6 wk after induction of heart failure. In line with previous studies, we found that SOL from CHF animals displayed an apparent fall in maximal force development during the protocol, as well as slower contraction and relaxation rates compared with sham at 42 days. However, at 112 days, there were no differences in contractile function, and CHF animals showed no sign of fatigue compared with sham. Previous findings of increased skeletal muscle fatigability have not considered this as a possible temporary phenomenon. We have previously shown that the higher maximal force in CHF rats compared with sham is probably due to the increases in contraction and relaxation time in these animals (16) . As the length of the contraction cycle increases, the muscle is not allowed to fully relax before the next stimulation. Consequently, there will be a slight summation and measured maximal force increases. Heparan sulfate proteoglycans (HSPGs) are important in linking together the fibrous elements of the ECM (32, 42) . The HS GAG chains can interact with several molecules, such as VEGF and other growth factors, chemokines, and enzymes to modulate their functions (8) . The down-regulation of VEGF in IF of CHF rats seen at days 3 and 10 was apparently unrelated to the HSPGs as the content of disaccharides was similar for HS chains for the CHF and sham groups. The ratio of CS ϩ hyaluronan/HS was also unaltered in skeletal muscles of CHF rats compared with sham, indicating no differences between the two groups in the total amount of GAGs.
VEGF is present in the skeletal muscle interstitium of humans (12) and rats (22) , and previous studies have suggested a role for VEGF in the regulation of MMP activity (40, 47) . Here, we hypothesized that an early activation of a cytokine response might trigger skeletal muscle ECM alterations. A main finding was a reduced level of VEGF in the IF of CHF rats at 3 and 10 days. Notably, we previously reported unaltered capillarization 6 wk after CHF induction (30) , and here, we report a highly significant reduction of VEGF in the IF of CHF rats followed by an increased MMP activity. VEGF signaling occurs by binding to VEGF receptors (VEGFRs), and the ligand-receptor complex may be internalized, thus removing VEGF from the IF. Interestingly, therefore, the large concentration gradient of VEGF from the muscle IF to plasma in both CHF and sham animals at all time points indicates a net production of VEGF in the muscle. Furthermore, VEGFRs have been shown to induce MMP-9 (11), which besides MMP-2, accounts for most of the gelatinase activity. Although not formally tested, an upregulation of VEGFRs could potentially explain both the initially reduced VEGF and the subsequent increase in MMP activity.
In conclusion, we found little evidence to support a role for any sustained alteration of muscular ECM in overt CHF. However, we found early changes in muscular VEGF levels, and the subsequent temporary alterations in MMP activity and collagen content were time-related to increased skeletal muscle fatigability.
Perspectives and Significance
Increased skeletal muscle fatigability related to intrinsic alterations in the muscle in CHF patients seems thoroughly documented (5, 20, 36, 44) . However, in the present study we could not demonstrate skeletal muscle fatigue or ECM alterations at a late stage after induction of heart failure in rats by coronary ligation. Possibly, this postinfarction rat model of CHF might be less biologically useful than previously assumed to investigate the mechanisms of skeletal muscle fatigue relevant for CHF patients. Alternatively, the reduced resistance to fatigue in skeletal muscles in CHF patients may not be directly mechanistically related to the heart failure condition, but rather to some epiphenomenon, e.g., deconditioning. Consequently, both basic research and clinical studies are needed to unravel the possible direct links between early-onset alterations in ECM and the development of fatigue within individual skeletal muscle fibers.
